TY - JOUR
T1 - The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder
AU - MacHado-Vieira, Rodrigo
AU - Pivovarova, Natalia B.
AU - Stanika, Ruslan I.
AU - Yuan, Peixiong
AU - Wang, Yun
AU - Zhou, Rulun
AU - Zarate, Carlos A.
AU - Drevets, Wayne C.
AU - Brantner, Christine A.
AU - Baum, Amber
AU - Laje, Gonzalo
AU - McMahon, Francis J.
AU - Chen, Guang
AU - Du, Jing
AU - Manji, Husseini K.
AU - Andrews, S. Brian
N1 - Funding Information:
This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Mental Health (NIMH), and National Institute of Neurological Disorders and Stroke . Data and biomaterials were collected in four projects that participated in the NIMH Bipolar Disorder Genetics Initiative. From 1991 to 1998, the Principal Investigators and Co-Investigators were: Indiana University, Indianapolis, Indiana, U01 MH46282, John Nurnberger, M.D., Ph.D., Marvin Miller, M.D., and Elizabeth Bowman, M.D.; Washington University, St. Louis, Missouri, U01 MH46280, Theodore Reich, M.D., Allison Goate, Ph.D., and John Rice, Ph.D.; Johns Hopkins University, Baltimore, Maryland U01 MH46274, J. Raymond DePaulo, Jr., M.D., Sylvia Simpson, M.D., MPH, and Colin Stine, Ph.D.; NIMH Intramural Research Program, Clinical Neurogenetics Branch, Bethesda, Maryland, Elliot Gershon, M.D., Diane Kazuba, B.A., and Elizabeth Maxwell, M.S.W.
Funding Information:
This work was sponsored by NIMH Grants MH52618 and MH058693 . Genotyping services were provided by the Center for Inherited Disease Research. The Center for Inherited Disease Research is fully funded through a federal contract from the NIH to The Johns Hopkins University, Contract Number N01-HG-65403 . Data and biomaterials were collected and supported by NIMH Grant R01 MH59602 (to Miron Baron, M.D.) and by funds from the Columbia Genome Center and the New York State Office of Mental Health . The main contributors to this work were Miron Baron, M.D. (Principal Investigator), Jean Endicott, Ph.D. (Co-Principal Investigator), Jo Ellen Loth, M.S.W., John Nee, Ph.D, Richard Blumenthal, Ph.D., Lawrence Sharpe, M.D., Barbara Lilliston, M.S.W., Melissa Smith, M.A., and Kristine Trautman, M.S.W., all from the Columbia University Department of Psychiatry, New York, New York. A small subset of the sample was collected in Israel in collaboration with Bernard Lerer, M.D., and Kyra Kanyas, M.S., from the Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Funding Information:
We gratefully acknowledge the support of the Intramural Research Program of the NIMH and National Institute of Neurological Disorders and Stroke , NIH , Department of Health and Human Services . Dr. Manji is now Global Therapeutic Area Head, Johnson & Johnson Pharmaceuticals, and a full time employee of Johnson & Johnson. Dr. Zarate is listed as a co-inventor on a patent for the use of ketamine in major depression. Dr. Zarate has assigned his patent rights on ketamine to the US Government. All authors declare that, except for income received from our primary employer, no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research or professional service and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.
PY - 2011/2/15
Y1 - 2011/2/15
N2 - Background Bipolar disorder (BPD) is characterized by altered intracellular calcium (Ca2+) homeostasis. Underlying mechanisms involve dysfunctions in endoplasmic reticulum (ER) and mitochondrial Ca2+ handling, potentially mediated by B-cell lymphoma 2 (Bcl-2), a key protein that regulates Ca2+ signaling by interacting directly with these organelles, and which has been implicated in the pathophysiology of BPD. Here, we examined the effects of the Bcl-2 gene single nucleotide polymorphism (SNP) rs956572 on intracellular Ca2+ dynamics in patients with BPD. Methods Live cell fluorescence imaging and electron probe microanalysis were used to measure intracellular and intra-organelle free and total calcium in lymphoblasts from 18 subjects with BPD carrying the AA, AG, or GG variants of the rs956572 SNP. Analyses were carried out under basal conditions and in the presence of agents that affect Ca2+ dynamics. Results Compared with GG homozygotes, variant AAwhich expresses significantly reduced Bcl-2 messenger RNA and proteinexhibited elevated basal cytosolic Ca2+ and larger increases in inositol 1,4,5-trisphosphate receptormediated cytosolic Ca 2+ elevations, the latter in parallel with enhanced depletion of the ER Ca2+ pool. The aberrant behavior of AA cells was reversed by chronic lithium treatment and mimicked in variant GG by a Bcl-2 inhibitor. In contrast, no differences between SNP variants were found in ER or mitochondrial total Ca2+ content or in basal store-operated Ca2+ entry. Conclusions These results demonstrate that, in patients with BPD, abnormal Bcl-2 gene expression in the AA variant contributes to dysfunctional Ca2+ homeostasis through a specific ER inositol 1,4,5-trisphosphate receptordependent mechanism.
AB - Background Bipolar disorder (BPD) is characterized by altered intracellular calcium (Ca2+) homeostasis. Underlying mechanisms involve dysfunctions in endoplasmic reticulum (ER) and mitochondrial Ca2+ handling, potentially mediated by B-cell lymphoma 2 (Bcl-2), a key protein that regulates Ca2+ signaling by interacting directly with these organelles, and which has been implicated in the pathophysiology of BPD. Here, we examined the effects of the Bcl-2 gene single nucleotide polymorphism (SNP) rs956572 on intracellular Ca2+ dynamics in patients with BPD. Methods Live cell fluorescence imaging and electron probe microanalysis were used to measure intracellular and intra-organelle free and total calcium in lymphoblasts from 18 subjects with BPD carrying the AA, AG, or GG variants of the rs956572 SNP. Analyses were carried out under basal conditions and in the presence of agents that affect Ca2+ dynamics. Results Compared with GG homozygotes, variant AAwhich expresses significantly reduced Bcl-2 messenger RNA and proteinexhibited elevated basal cytosolic Ca2+ and larger increases in inositol 1,4,5-trisphosphate receptormediated cytosolic Ca 2+ elevations, the latter in parallel with enhanced depletion of the ER Ca2+ pool. The aberrant behavior of AA cells was reversed by chronic lithium treatment and mimicked in variant GG by a Bcl-2 inhibitor. In contrast, no differences between SNP variants were found in ER or mitochondrial total Ca2+ content or in basal store-operated Ca2+ entry. Conclusions These results demonstrate that, in patients with BPD, abnormal Bcl-2 gene expression in the AA variant contributes to dysfunctional Ca2+ homeostasis through a specific ER inositol 1,4,5-trisphosphate receptordependent mechanism.
KW - Bcl-2
KW - bipolar disorder
KW - calcium
KW - electron probe microanalysis
KW - endoplasmic reticulum
KW - inositol 1;4;5-trisphosphate
KW - mania
KW - mitochondria
UR - http://www.scopus.com/inward/record.url?scp=79151470598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79151470598&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2010.10.019
DO - 10.1016/j.biopsych.2010.10.019
M3 - Article
C2 - 21167476
AN - SCOPUS:79151470598
SN - 0006-3223
VL - 69
SP - 344
EP - 352
JO - Biological psychiatry
JF - Biological psychiatry
IS - 4
ER -